Apertura Gene Therapy
Newyork
About Apertura Gene Therapy
Apertura Gene Therapy offers treatment options for debilitating diseases with few options. It is in a unique position to develop genetic medicines by simultaneously engineering AAV capsids, regulatory elements, and payloads to overcome current gene therapy limitations. They are dedicated to the advancement of gene therapy and believe that by collaborating with corporate and academic partners, patients, and disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2022)
- Website: aperturagtx.com
- Phone: 1.555.918.8251
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/apertura-gene-therapy-172542 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.